Article

Selective ablation of adult GFAP-expressing tanycytes leads to hypogonadotropic…

medRxiv · 2021 · BUTRUILLE, L.; BATAILLER, M.; CATEAU, M.-L.; SHARIF, A.; LEYSEN, V.; PREVOT, V.; VAUDIN, P.; PILLON, D.; MIGAUD, M.

Key facts

Title Selective ablation of adult GFAP-expressing tanycytes leads to hypogonadotropic hypogonadism in males
First author BUTRUILLE, L.; BATAILLER, M.; CATEAU, M.-L.; SHARIF, A.; LEYSEN, V.; PREVOT, V.; VAUDIN, P.; PILLON, D.; MIGAUD, M.
Journal medRxiv
Published Aug 1, 2021
DOI 10.1101/2021.07.31.454492
Devices mentioned K040782, K800552, K853723, K860811, K862004, K874160, K874609, K912581, K915561, K915840, K920529, K920967 and 11 more
Product codes mentioned EPT, GCJ, GCT, GEX, HET, HJO, HLI, HLQ, HQF, JAK, KKX, JJH and 2 more

At a glance

  • 10–99 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature